Original article

Scand J Work Environ Health 2023;49(6):386-394    pdf full text

https://doi.org/10.5271/sjweh.4103 | Published online: 07 Jul 2023, Issue date: 01 Sep 2023

Occupational risks associated with severe COVID-19 disease and SARS-CoV-2 infection – a Swedish national case-control study conducted from October 2020 to December 2021

by Torén K, Albin M, Bergström T, Murgia N, Alderling M, Schiöler L, Åberg M

Objective This study aimed to investigate whether workplace factors and occupations are associated with SARS-CoV-2 infection or severe COVID-19 in the later waves of the pandemic.

Methods We studied 552 562 cases with a positive test for SARS-CoV-2 in the Swedish registry of communicable diseases, and 5985 cases with severe COVID-19 based on hospital admissions from October 2020 to December 2021. Four population controls were assigned the index dates of their corresponding cases. We linked job histories to job-exposure matrices to assess the odds for different transmission dimensions and different occupations. We used adjusted conditional logistic analyses to estimate odds ratios (OR) for severe COVID-19 and SARS-CoV-2 with 95% confidence intervals (CI).

Results The highest OR for severe COVID-19 were for: regular contact with infected patients, (OR 1.37, 95% CI 1.23–1.54), close physical proximity (OR 1.47, 95% CI 1.34–1.61), and high exposure to diseases or infections (OR 1.72, 95% CI 1.52–1.96). Mostly working outside had lower OR (OR 0.77, 95% CI 0.57–1.06). The odds for SARS-CoV-2 when mostly working outside were similar (OR 0.83, 95% CI 0.80–0.86). The occupation with the highest OR for severe COVID-19 (compared with low-exposure occupations) was certified specialist physician (OR 2.05, 95% CI 1.31–3.21) among women and bus and tram drivers (OR 2.04, 95% CI 1.49–2.79) among men.

Conclusions Contact with infected patients, close proximity and crowded workplaces increase the risks for severe COVID-19 and SARS-CoV-2 infection. Outdoor work is associated with decreased odds for SARS-CoV-2 infection and severe COVID-19.

This article refers to the following texts of the Journal: 2022;48(1):61-70  2022;48(8):672-677  2023;49(1):84-94  2023;49(3):171-181  2022;48(7):530-539
The following article refers to this text: 2024;50(3):168-177
Download additional material